NCT06322342 2025-12-26Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast AgentReveal Pharmaceuticals Inc.Phase 2 Completed18 enrolled
NCT05305378 2024-08-07Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood FlowDynamic LightCompleted8 enrolled
NCT03936426 2020-04-20Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATEâ„¢Clarity Pharmaceuticals LtdPhase 1/2 Completed5 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00006368 2013-05-01Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNovartisPhase 1 Completed60 enrolled